- Investing Ideas
- Danish Pharmaceuticals & Biotech High Insider Buying
Danish Pharmaceuticals & Biotech High Insider Buying
Results
3
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
3 companies
H. Lundbeck
Market Cap: DKK 36.4b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 37.48
7D
-2.3%
1Y
-4.5%
ChemoMetec
Market Cap: DKK 7.0b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 400.60
7D
-4.8%
1Y
-21.9%
Gubra
Market Cap: DKK 6.0b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 368.60
7D
-6.9%
1Y
-26.6%